Activity OverviewThe Pediatric Virtual Lupus Clinic is a two-part series with case-based learning to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine two patients, each presenting with different symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed.Case 1 is a 13-year-old Black female with fatigue and joint pain.Case 2 is a 14-year-old Hispanic male with fatigue, facial swelling, and intermittent chest pain. Pediatric Virtual Lupus Clinic SeriesThis activity is part of a series. See the other activities in the series below:Pediatric Virtual Lupus Clinic Series: Case 1 Pediatric Virtual Lupus Clinic Series: Case 2Registration is complimentary.Target AudiencePrimary care providers, advanced practice nurses, physician assistants.Learning ObjectivesUpon completion of this activity, participants should be able to:Case 1Identify when lupus should be suspectedUse appropriate baseline labs and recognize when an ANA is appropriateDescribe different skin findings and how differences in skin tones can affect the way a rash looksImplement co-management and referral triaging for a patientCase 2Identify when lupus should be suspectedIdentify lupus signs and symptoms and when to suspect renal diseaseExamine a differential diagnosis for individuals presenting with a combination of renal and pulmonary diseaseCE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet. AMA Designation Statement The American College of Rheumatology designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by December 1, 2027, at 11:59 PM ET. MOCMOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal. MOC Recognition Statement: American Board of Pediatrics (ABP)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.MOC points must be claimed by December 1, 2027, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity. Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.Planning CommitteeThe following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.Emily F. Beil, MDAnita Dhanrajani, MBBS, MScMarla Guzman, MD Joseph McDonald, MD, MS, RhMSUSMichael Bradley Nelson, MD, MPHJessica Perfetto, MDHeather Walters, MDReviewersThe following reviewers have no relevant financial relationship(s) with ineligible companies to disclose.Sheira Neely, APRN, CPNPCarolyn Zic, APRN, FNP-BCAcknowledgement of Commercial SupportThis activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100 percent funded by CDC/HHS. The activity content was provided by the author(s) and does not necessarily represent the official views of, nor an endorsement by, the CDC/HHS or U.S. Government.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe Pediatric Virtual Lupus Clinic is a case-based learning activity to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist. You will virtually examine the patient, determine symptoms, decide which labs to order, build the differential diagnosis, and decide next steps for treating the patient, including appropriate referrals, if needed. Case 2 is a 14-year-old Hispanic male with fatigue, facial swelling, and intermittent chest pain.Pediatric Virtual Lupus Clinic SeriesThis activity is part of a series. See the other activities in the series below:Pediatric Virtual Lupus Clinic Series: All ActivitiesPediatric Virtual Lupus Clinic Series: Case 1 Registration is complimentary.Target AudiencePrimary care providers, advanced practice nurses, physician assistants.Learning ObjectivesUpon completion of this activity, participants should be able to:Identify when lupus should be suspectedIdentify lupus signs and symptoms and when to suspect renal diseaseExamine a differential diagnosis for individuals presenting with a combination of renal and pulmonary diseaseCE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.AMA Designation StatementThe American College of Rheumatology designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by December 1, 2027, at 11:59 PM ET. MOCMOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.MOC Recognition Statement: American Board of Pediatrics (ABP)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal. MOC points must be claimed by December 1, 2027, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify details None: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.Planning CommitteeThe following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose. Emily F. Beil, MDAnita Dhanrajani, MBBS, MScMarla Guzman, MDJoseph McDonald, MD, MS, RhMSUSMichael Bradley Nelson, MD, MPHJessica Perfetto, MDHeather Walters, MD   Reviewers The following reviewers have no relevant financial relationship(s) with ineligible companies to disclose. Sheira Neely, APRN, CPNPCarolyn Zic, APRN, FNP-BCAcknowledgement of Commercial SupportThis activity is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award of $7 million with 100 percent funded by CDC/HHS. The activity content was provided by the author(s) and does not necessarily represent the official views of, nor an endorsement by, the CDC/HHS or U.S. Government. Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.